AIDS Denialism and Public Health Practice (original) (raw)
Chigwedere P, Seage GR 3rd, Gruskin S, Lee TH, Essex M. Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr. 2008;49:410–5. PubMed Google Scholar
Nattrass N. AIDS and the scientific governance of medicine in post-apartheid South Africa. African Affairs. 2008;107:157–76. Google Scholar
Duesberg PH, Nicholson JM, Rasnick D, Fiala C, Bauer HH. HIV-AIDS hypothesis out of touch with South African AIDS—a new perspective. Med Hypotheses. 2009; Epub ahead of print (withdrawn).
Lenzer J. AIDS “dissident” seeks redemption… and a cure for cancer. Discover. 2008;29(6):44–50. Google Scholar
Duesberg P. HIV is not the cause of AIDS. Science. 1988;241(4865):514, 517. Other of Duesberg’s writings available at: <http://www.duesberg.com/>. Accessed 2009 Nov 17.
Baleta A. South Africa’s AIDS care thrown into confusion. Lancet. 1999;354:1711. CASPubMed Google Scholar
Cohen J. South Africa. AIDS researchers decry Mbeki’s views on HIV. Science. 2000;288:590–1. CASPubMed Google Scholar
Horton R. Mbeki defiant about South African HIV/AIDS strategy. Lancet. 2000;356(9225):225. CASPubMed Google Scholar
Masland T, King P. Flirting with strange ideas. Mbeki reaches out to a controversial AIDS researcher. Newsweek. 2000;135(16):36. CASPubMed Google Scholar
Essex M, Mboup S. The etiology of AIDS. In: Essex M, Mboup S, Kanki P, Marlink R, Tlou S, editors. AIDS in Africa. New York: Kluwer Academic/Plenum; 2002. p. 1–10. Google Scholar
Gottlieb MS, Schroff R, Schanker HM, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981;305(24):1425–31. CASPubMed Google Scholar
Masur H, Michelis MA, Greene JB, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med. 1981;305(24):1431–8. ArticleCASPubMed Google Scholar
Siegal FP, Lopez C, Hammer GS, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med. 1981;305(24):1439–44. CASPubMed Google Scholar
Epidemiological aspects of the current outbreak of Kaposi’s sarcoma and opportunistic infections. N Engl J Med. 1982; 306: 248–52.
Masur H, Michelis MA, Wormser GP, et al. Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med. 1982;97(4):533–9. CASPubMed Google Scholar
Davis KC, Horsburgh CR Jr, Hasiba U, Schocket AL, Kirkpatrick CH. Acquired immunodeficiency syndrome in a patient with hemophilia. Ann Intern Med. 1983;98(3):284–6. CASPubMed Google Scholar
Poon MC, Landay A, Prasthofer EF, Stagno S. Acquired immunodeficiency syndrome with Pneumocystis carinii pneumonia and _Mycobacterium avium_-intracellulare infection in a previously healthy patient with classic hemophilia. Clinical, immunologic, and virologic findings. Ann Intern Med. 1983;98(3):287–90. CASPubMed Google Scholar
Jett JR, Kuritsky JN, Katzmann JA, Homburger HA. Acquired immunodeficiency syndrome associated with blood-product transfusions. Ann Intern Med. 1983;99(5):621–4. CASPubMed Google Scholar
Curran JW, Lawrence DN, Jaffe H, et al. Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med. 1984;310(2):69–75. ArticleCASPubMed Google Scholar
Rubinstein A, Sicklick M, Gupta A, et al. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA. 1983;249(17):2350–6. CASPubMed Google Scholar
Francis DP, Curran JW, Essex M. Epidemic acquired immune deficiency syndrome: epidemiologic evidence for a transmissible agent. J Natl Cancer Inst. 1983;71(1):1–4. CASPubMed Google Scholar
Durack DT. Opportunistic infections and Kaposi’s sarcoma in homosexual men. N Engl J Med. 1981;305(24):1465–7. ArticleCASPubMed Google Scholar
Kitchen LW, Barin F, Sullivan JL, et al. Aetiology of AIDS—antibodies to human T-cell leukaemia virus (type III) in haemophiliacs. Nature. 1984;312(5992):367–9. CASPubMed Google Scholar
Sarngadharan MG, Popovic M, Bruch L, Schüpbach J, Gallo RC. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science. 1984;224(4648):506–8. CASPubMed Google Scholar
Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220(4599):868–71. CASPubMed Google Scholar
Gallo RC, Sarin PS, Gelmann EP, et al. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science. 1983;220(4599):865–7. CASPubMed Google Scholar
Aschengrau A, Seage GR. Essentials of epidemiology in public health. 2nd ed. Sudbury, MA: Jones & Bartlett; 2008. p. 383–410. Google Scholar
Knight DC, Schrotter G. Robert Koch: father of bacteriology. New York: Franklin Watts; 1961. Google Scholar
Ambrose Z, KewalRamani VN, Bieniasz PD, Hatziioannou T. HIV/AIDS: in search of an animal model. Trends Biotechnol. 2007;25(8):333–7. CASPubMed Google Scholar
Cohen J. Fulfilling Koch’s postulates. Science. 1994;266:1647. Google Scholar
O’Brien SJ, Goedert JJ. HIV causes AIDS: Koch’s postulates fulfilled. Curr Opin Immunol. 1996;8(5):613–8. PubMed Google Scholar
Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300. CASPubMed Google Scholar
Schechter MT, Craib KJ, Gelmon KA, Montaner JS, Le TN, O’Shaughnessy MV. HIV-1 and the aetiology of AIDS. Lancet. 1993;341(8846):658–9. CASPubMed Google Scholar
Darby SC, Ewart DW, Giangrande PL, Dolin PJ, Spooner RJ, Rizza CR. Mortality before and after HIV infection in the complete UK population of haemophiliacs. UK Haemophilia Centre Directors’ Organisation. Nature. 1995;377(6544):79–82. CASPubMed Google Scholar
Biggar RJ. AIDS incubation in 1891 HIV seroconverters from different exposure groups. International Registry of Seroconverters. AIDS. 1990;4(11):1059–66. CASPubMed Google Scholar
Prins M, Veugelers PJ. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study. AIDS. 1997;11(5):621–31. CASPubMed Google Scholar
Engels EA, Rosenberg PS, O’Brien TR, Goedert JJ. Plasma HIV viral load in patients with hemophilia and late-stage HIV disease: a measure of current immune suppression. Multicenter Hemophilia Cohort Study. Ann Intern Med. 1999;131(4):256–64. CASPubMed Google Scholar
Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272(5265):1167–70. CASPubMed Google Scholar
Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 1997;337:725–33. CASPubMed Google Scholar
Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. N Engl J Med. 1996;335(15):1091–8. CASPubMed Google Scholar
O’Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med. 1996;334(7):426–31. PubMed Google Scholar
Levy JA. HIV and the pathogenesis of AIDS. 3rd ed. Washington: ASM Press; 2007. Google Scholar
Knipe DM, Howley PM, editors. Fields’ virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. Google Scholar
Cohen J. Duesberg and critics agree: hemophilia is the best test. Science. 1994;266:1645–6. CASPubMed Google Scholar
Horton R. Will Duesberg now concede defeat? Lancet. 1995;346(8976):656. CASPubMed Google Scholar
Blattner W, Gallo RC, Temin HM. HIV causes AIDS. Science. 1988;241(4865):515–6. CASPubMed Google Scholar
Pachl C, Todd JA, Kern DG, et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(5):446–54. CASPubMed Google Scholar
Henrard DR, Phillips JF, Muenz LR, et al. Natural history of HIV-1 cell-free viremia. JAMA. 1995;274(7):554–8. CASPubMed Google Scholar
Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science. 1995;267(5197):483–9. CASPubMed Google Scholar
Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995;373(6510):123–6. CASPubMed Google Scholar
Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med. 1996;334(16):1011–7. CASPubMed Google Scholar
Essex M, Mboup S, Kanki P, Marlink R, Tlou S, editors. AIDS in Africa. New York: Kluwer Academic/Plenum; 2002. Google Scholar
Lu Y, Essex M, editors. AIDS in Asia. New York: Kluwer Academic/Plenum; 2004. Google Scholar
Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 10. Google Scholar
Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 169. Google Scholar
Duesberg PH, Rasnick D. The AIDS dilemma: drug diseases blamed on a passenger virus. Genetica. 1998;104:85–132. CASPubMed Google Scholar
Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 255–97. Google Scholar
Duesberg PH. Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation. Proc Natl Acad Sci USA. 1989;86:755–64. CASPubMed Google Scholar
Duesberg PH. AIDS epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease. Proc Natl Acad Sci USA. 1991;88:1575–9. CASPubMed Google Scholar
Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 175. Google Scholar
Duesberg PH. Duesberg defends challenges to the existence of HIV. Continuum. 1996;4(2):8–9. Google Scholar
Duesberg PH. The role of drugs in the origin of AIDS. Biomed Pharmacother. 1992;46:3–15. CASPubMed Google Scholar
Duesberg PH. Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV. Genetica. 1995;95:51–70. CASPubMed Google Scholar
Allain JP. Transfusion risks of yesterday and of today. Transfus Clin Biol. 2003;10(1):1–5. PubMed Google Scholar
Duesberg P, Koehnlein C, Rasnick D. The chemical bases of the various AIDS epidemics: recreational drugs, anti-viral chemotherapy and malnutrition. J Biosci. 2003;28(4):383–412. PubMed Google Scholar
Kalichman SC. Denying AIDS: conspiracy theories, pseudoscience, and human tragedy. New York and London: Copernicus/Springer; 2009. p. 44. Google Scholar
Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 184–5. Google Scholar
Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 187. Google Scholar
Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 419. Google Scholar
UNAIDS. Report on the global HIV/AIDS epidemic. Geneva: UNAIDS; 2008. Google Scholar
Barnhart HX, Caldwell MB, Thomas P, et al. Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. Pediatrics. 1996;97(5):710–6. CASPubMed Google Scholar
European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet. 1991;337(8736):253–60. Google Scholar
Newell ML, Borja MC, Peckham C. European Collaborative Study. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics. 2003;111(1):e52–60. PubMed Google Scholar
UNAIDS. Report on the global HIV/AIDS epidemic. Geneva: UNAIDS; 2000. Google Scholar
Duesberg PH. AIDS acquired by drug consumption and other noncontagious risk factors. Pharmac Ther. 1992;55:201–77. CAS Google Scholar
Msisha WM, Kapiga SH, Earls F, Subramanian SV. Socioeconomic status and HIV seroprevalence in Tanzania: a counterintuitive relationship. Int J Epidemiol. 2008;37(6):1297–303. PubMed Google Scholar
Piot P, Greener R, Russell S. Squaring the circle: AIDS, poverty, and human development. PLoS Med. 2007;4(10):1571–5. PubMed Google Scholar
Begtrup K, Melbye M, Biggar RJ, Goedert JJ, Knudsen K, Andersen PK. Progression to acquired immunodeficiency syndrome is influenced by CD4 T-lymphocyte count and time since seroconversion. Am J Epidemiol. 1997;145(7):629–35. CASPubMed Google Scholar
Vermund SH, Hoover DR, Chen K. CD4+ counts in seronegative homosexual men. The Multicenter AIDS Cohort Study. N Engl J Med. 1993;328(6):442. CASPubMed Google Scholar
Des Jarlais DC, Friedman SR, Marmor M, et al. CD4 lymphocytopenia among injecting drug users in New York City. J Acquir Immune Defic Syndr. 1993;6(7):820–2. CASPubMed Google Scholar
Donegan E, Stuart M, Niland JC, et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med. 1990;113(10):733–9. CASPubMed Google Scholar
Hughes SM, Amadi B, Mwiya M, et al. CD4 counts decline despite nutritional recovery in HIV-infected Zambian children with severe malnutrition. Pediatrics. 2009;123(2):e347–51. PubMed Google Scholar
Aina O, Dadik J, Charurat M, et al. Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult Nigerians. Clin Diagn Lab Immunol. 2005;12(4):525–30. CASPubMed Google Scholar
Maclure M. Inventing the AIDS virus hypothesis: an illustration of scientific vs unscientific induction. Epidemiology. 1998;9(4):467–73. CASPubMed Google Scholar
Kalichman SC. Denying AIDS: conspiracy theories, pseudoscience, and human tragedy. New York and London: Copernicus/Springer; 2009. p. 9. Google Scholar
Schünemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations. Health Res Policy Syst. 2006;4:21. PubMed Google Scholar
Chin R, Lee BY. Principles and practice of clinical trial medicine. London: Academic Press; 2008. Google Scholar
Light RJ, Pillemer DB. Summing up: the science of reviewing research. Cambridge: Harvard University Press; 1984. Google Scholar
Egger M, Davey Smith G, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ; 2001. Google Scholar
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354(9193):1896–900. CASPubMed Google Scholar
Chigwedere P, Seage GR, Lee TH, Essex M. Efficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: a meta-analysis of published clinical trials. AIDS Res Hum Retroviruses. 2008;24(6):827–37. CASPubMed Google Scholar
Atkins D, Best D, Briss PA, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. PubMed Google Scholar
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12. CASPubMed Google Scholar
Institute of Medicine. Adverse events associated with childhood vaccines: evidence bearing on causality. Washington: National Academy Press; 1993. Google Scholar
Stoto MA. Research synthesis for public health policy: experience of the Institute of Medicine. In: Stangl D, Berry D, editors. Meta-analysis in medicine and health policy. New York: Marcel Dekker; 2000. Google Scholar
Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2007;1:CD003510. PubMed Google Scholar
Suksomboon N, Poolsup N, Ket-Aim S. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection. J Clin Pharm Ther. 2007;32:293–311. CASPubMed Google Scholar
Bartlett JA, Benoit SL, Johnson VA, et al. Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party. Ann Intern Med. 1996;125(3):161–72. CASPubMed Google Scholar
Nachman SA, Stanley K, Yogev R, et al. Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team. JAMA. 2000;283(4):492–8. CASPubMed Google Scholar
Darbyshire J, Foulkes M, Peto R, et al. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults. Cochrane Database Syst Rev. 2000;3:CD002038. PubMed Google Scholar
Jordan R, Gold L, Cummins C, Hyde C. Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy. BMJ. 2002;324(7340):757. CASPubMed Google Scholar
Rutherford G, Sangani P, Kennedy GE. Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection. Cochrane Database Syst Rev. 2003;3:CD002037. Google Scholar
Siegfried N, van Deventer PJU, Mahomed FA, Rutherford G. Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults. Cochrane Database Syst Rev. 2006;2:CD004535. PubMed Google Scholar
Humphreys E, Hernandez LB, Rutherford G. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy. Cochrane Database Syst Rev. 2007;4:CD006517. PubMed Google Scholar
Shey M, Kongnyuy EJ, Shang J, Wiysonge CS. A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS. Cochrane Database Syst Rev. 2009;3:CD005481. PubMed Google Scholar
Djomand G, Roels T, Ellerbrock T, et al. Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Cote d’Ivoire. AIDS. 2003;17(Suppl 3):S5–15. ArticlePubMed Google Scholar
Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;18(6):887–95. PubMed Google Scholar
Wester CW, Kim S, Bussmann H, et al. Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. J Acquir Immune Defic Syndr. 2005;40(3):336–43. PubMed Google Scholar
Etard JF, Ndiaye I, Thierry-Mieg M, et al. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS. 2006;20(8):1181–9. PubMed Google Scholar
Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006;296(7):782–93. CASPubMed Google Scholar
Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis. 2005;41(2):217–24. CASPubMed Google Scholar
Hammond R, Harry TC. Efficacy of antiretroviral therapy in Africa: effect on immunological and virological outcome measures: a meta-analysis. Int J STD AIDS. 2008;19(5):291–6. PubMed Google Scholar
Braitstein P, Brinkhof MW, Dabis F, et al. Antiretroviral therapy in lower income countries (ART-LINC) collaboration; ART cohort collaboration (ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367(9513):817–24. PubMed Google Scholar
Preston S, Heuveline P, Guillot M. Demography: measuring and modeling population processes. Oxford: Wiley-Blackwell; 2000. p. 1–20. Google Scholar
Statistics South Africa. Mortality and causes of death in South Africa, 2006: findings from death notification. South Africa: Statistics South Africa; 2008. Google Scholar
Stanecki KA, Walker N. Current estimates and projections for the epidemic. In: Essex M, Mboup S, Kanki P, Marlink R, Tlou S, editors. AIDS in Africa. New York: Kluwer Academic/Plenum; 2002. p. 281–96. Google Scholar
Dorrington R, Bourne D, Bradshaw D, Laubscher R, Timæus I. The impact of HIV/AIDS on adult mortality in South Africa. Burden of Disease Research Unit, Medical Research Council (SA); 2001:10. Available at: <http://www.mrc.ac.za/bod/complete.pdf> . Accessed 2009 Aug 9.
UNAIDS Reference Group on Estimates, Modelling and Projections. Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections. AIDS. 2002;16(9):W1–14. Google Scholar
Walker N, Stanecki KA, Brown T, et al. Methods and procedures for estimating HIV/AIDS and its impact: the UNAIDS/WHO estimates for the end of 2001. AIDS. 2003;17(15):2215–25. PubMed Google Scholar
Stover J, Johnson P, Zaba B, Zwahlen M, Dabis F, Ekpini RE. The spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect. 2008;84(Suppl 1):i24–30. PubMed Google Scholar
Stover J, Ghys PD, Walker N. Testing the accuracy of demographic estimates in countries with generalized epidemics. AIDS. 2004;18(Suppl 2):S67–73. PubMed Google Scholar
Grassly NC, Morgan M, Walker N, et al. Uncertainty in estimates of HIV/AIDS: the estimation and application of plausibility bounds. Sex Transm Infect. 2004;80(Suppl 1):i31–8. PubMed Google Scholar
Walker N, Grassly NC, Garnett GP, Stanecki KA, Ghys PD. Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic? Lancet. 2004;363(9427):2180–5. PubMed Google Scholar
Gouws E, Mishra V, Fowler TB. Comparison of adult HIV prevalence from national population-based surveys and antenatal clinic surveillance in countries with generalised epidemics: implications for calibrating surveillance data. Sex Transm Infect. 2008;84(Suppl 1):i17–23. PubMed Google Scholar
Actuarial Society of South Africa. ASSA 2003 AIDS and demographic model. Cape Town: Actuarial Society of South Africa; 2005. Google Scholar
Boerma JT, Nunn AJ, Whitworth JA. Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries. AIDS. 1998;12(Suppl 1):S3–14. PubMed Google Scholar
Blacker J. The impact of AIDS on adult mortality: evidence from national and regional statistics. AIDS. 2004;18(Suppl 2):S19–26. PubMed Google Scholar
Stover J, Way P. Projecting the impact of AIDS on mortality. AIDS. 1998;12(Suppl 1):S29–39. PubMed Google Scholar
The Durban Declaration. Nature 2000;406:15–6. Google Scholar
Horton R. African AIDS beyond Mbeki: tripping into anarchy. Lancet. 2000;356(9241):1541–2. CASPubMed Google Scholar
Kalichman SC. Denying AIDS: conspiracy theories, pseudoscience, and human tragedy. New York and London: Copernicus/Springer; 2009. p. 8–13. Google Scholar
Cameron E. Witness to AIDS. London: I. B. Tauris; 2005. Google Scholar
Moore JP. The dangers of denying HIV. Nature. 2009;459:168. CAS Google Scholar
Geffen N. Justice after AIDS denialism: should there be prosecutions and compensation? J Acquir Immune Defic Syndr. 2009;51(4):454–5. PubMed Google Scholar
Muga W. When public negligence can become criminal. African Business 2009 May.
Moore JP, Bergman J, Wainberg MA. The AIDS denialists are still around. IAS Newsl. 2007:4–5.
Chigwedere PM. Antiretroviral drug use in South Africa: from science to practice and malpractice (Dissertation). Boston: Harvard School of Public Health; 2008. Google Scholar